T. Rowe Price Associates
MMED

T. Rowe Price Associates’s MiniMed Group Inc MMED Stock Holding History

T. Rowe Price Associates’s Portfolio MMED Stock Details MMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354K Buy
+23,631
New +$312K ﹤0.01% 2778

Other funds holding MMED

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates's MMED Position: Q2 2026 in Review

T. Rowe Price Associates opened a new position in MiniMed Group Inc (MMED) in Q2 2026: 23,631 shares worth $354K. The stake represents ﹤0.01% of the portfolio and ranks #2778 among its holdings.

98 funds tracked by Wall St. Rank hold MMED as of Q2 2026.

  • T. Rowe Price Associates held 23,631 shares of MiniMed Group Inc worth $354K as of Q2 2026.
  • MiniMed Group Inc was a new T. Rowe Price Associates position in Q2 2026.
  • MiniMed Group Inc made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2778 holding.
  • 98 funds tracked by Wall St. Rank held MiniMed Group Inc as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.